Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free gadolinium ion (Gd³⁺) is the trivalent, ionic form of the chemical element gadolinium, an f-block rare earth metal with atomic number 64[1][7]. It has a [Xe] 4f⁷ electron configuration and is uniquely paramagnetic due to its seven unpaired electrons, accounting for its utility when complexed (chelated) in MRI contrast agents[4][7]. In biological systems, free Gd³⁺ is considered highly toxic because it can replace calcium in various physiological processes, leading to disruption of cellular function and toxicity[3][9]. For this reason, gadolinium is always administered as a chelated complex in medicine; release of free Gd³⁺ from these complexes can cause severe toxicity, including nephrogenic systemic fibrosis, particularly in patients with renal impairment[7][9]. The free ion itself has no known beneficial biological function and is not a validated therapeutic target[3][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free gadolinium ion (Gd³⁺).